Pascal Biosciences
shutterstock_309940142 (1).jpg

Press Releases

Press Releases

Date Title
11/05/18 Pascal Biosciences Announces Optimization of Cannabinoid-Derived Drug Candidates to Kill Glioblastoma Cells
10/30/18 Pascal Biosciences and the University of Washington Enter Into Exclusive License Agreement to Develop Cannabinoid-based Medicine for Cancer
07/16/18 Pascal Biosciences appoints Julie M. Eastland, accomplished financial executive, to Board of Directors
06/18/18 Pascal Biosciences Receives DEA Schedule I License for Cannabinoid Development and Renews UBC Collaboration
02/21/18 Pascal Biosciences Identifies Molecules in Cannabis That Stimulate the Immune System to Destroy Tumor Cells
12/05/17 Pascal Announces the Appointment of a New Director, Dr. Graeme I. Bell
09/11/17 Pascal Biosciences Acquires Technology to Treat Leukemia from the University of New Mexico
05/09/17 Pascal Biosciences Creates Development Science Lab in Seattle, WA
03/30/17 bioMmune Announces Name Change to Pascal Biosciences Inc.
11/14/16 bioMmune Announces Adoption of Advance Notice Policy
10/05/16 bioMmune Technologies Inc. Grants Stock Options
09/20/16 bioMmune Appoints Thomas Gadek, PhD, To Board of Directors